📊 PIIIW Key Takeaways
Is P3 Health Partners Inc. (PIIIW) a Good Investment?
P3 Health Partners exhibits severe financial distress with negative stockholders equity (-$155.2M), critically impaired liquidity (0.24x current ratio), and persistent negative operating cash flow (-$91.2M), despite extraordinary 2751% revenue growth. The company is technically insolvent with liabilities exceeding assets, and at current burn rates faces acute solvency risk without substantial capital infusion.
Why Buy P3 Health Partners Inc. Stock? PIIIW Key Strengths
- Exceptional revenue growth of 2751% YoY suggests successful merger integration or market expansion
- Net losses improving 54.2% YoY indicates trajectory toward profitability
- Significant revenue base of $1.5B provides scale if operational leverage can be achieved
PIIIW Stock Risks: P3 Health Partners Inc. Investment Risks
- Negative stockholders equity of -$155.2M indicates technical insolvency and negative book value
- Critical liquidity crisis with current ratio of 0.24x and only $25M cash against $796.9M liabilities
- Negative operating cash flow of -$91.2M and negative free cash flow indicate unsustainable cash burn
- Long-term debt of $228.4M cannot be supported by negative equity base
- Operating margin of -18.5% with -10.1% net margin shows business model not yet viable at scale
Key Metrics to Watch
- Operating cash flow trajectory toward positive territory
- Path to positive operating income and net profitability
- Debt restructuring or equity capital raise to address insolvency
- Liquidity position and covenant compliance with lenders
P3 Health Partners Inc. (PIIIW) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
PIIIW Profit Margin, ROE & Profitability Analysis
PIIIW vs Services Sector: How P3 Health Partners Inc. Compares
How P3 Health Partners Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is P3 Health Partners Inc. Stock Overvalued? PIIIW Valuation Analysis 2026
Based on fundamental analysis, P3 Health Partners Inc. has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
P3 Health Partners Inc. Balance Sheet: PIIIW Debt, Cash & Liquidity
PIIIW Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: P3 Health Partners Inc.'s revenue has grown significantly by 159% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.63 indicates the company is currently unprofitable.
PIIIW Revenue Growth, EPS Growth & YoY Performance
PIIIW Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $345.3M | -$31.6M | $-9.67 |
| Q2 2025 | $355.8M | -$12.0M | $-6.23 |
| Q1 2025 | $373.2M | -$18.7M | $-6.28 |
| Q3 2024 | $288.4M | -$13.3M | $-0.12 |
| Q2 2024 | $329.1M | -$9.8M | $-0.09 |
| Q1 2024 | $302.1M | -$9.2M | $-0.16 |
| Q3 2023 | $248.3M | -$11.2M | $-0.12 |
| Q2 2023 | $269.5M | -$9.8M | $-0.09 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
P3 Health Partners Inc. Dividends, Buybacks & Capital Allocation
PIIIW SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for P3 Health Partners Inc. (CIK: 0001832511)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PIIIW
What is the AI rating for PIIIW?
P3 Health Partners Inc. (PIIIW) has an AI rating of STRONG SELL with 98% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PIIIW's key strengths?
Claude: Exceptional revenue growth of 2751% YoY suggests successful merger integration or market expansion. Net losses improving 54.2% YoY indicates trajectory toward profitability.
What are the risks of investing in PIIIW?
Claude: Negative stockholders equity of -$155.2M indicates technical insolvency and negative book value. Critical liquidity crisis with current ratio of 0.24x and only $25M cash against $796.9M liabilities.
What is PIIIW's revenue and growth?
P3 Health Partners Inc. reported revenue of $1.5B.
Does PIIIW pay dividends?
P3 Health Partners Inc. does not currently pay dividends.
Where can I find PIIIW SEC filings?
Official SEC filings for P3 Health Partners Inc. (CIK: 0001832511) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PIIIW's EPS?
P3 Health Partners Inc. has a diluted EPS of $-45.26.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is PIIIW a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, P3 Health Partners Inc. has a STRONG SELL rating with 98% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is PIIIW stock overvalued or undervalued?
Valuation metrics for PIIIW: ROE of N/A (sector avg: 16%), net margin of -10.1% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy PIIIW stock in 2026?
Our dual AI analysis gives P3 Health Partners Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PIIIW's free cash flow?
P3 Health Partners Inc.'s operating cash flow is $-91.2M, with capital expenditures of $119.0K. FCF margin is -6.3%.
How does PIIIW compare to other Services stocks?
Vs Services sector averages: Net margin -10.1% (avg: 10%), ROE N/A (avg: 16%), current ratio 0.24 (avg: 1.5).